Advertisements
Advertisements
प्रश्न
Explain how recombinant human insulin was prepared in 1983 by Eli Lily an American company.
Advertisements
उत्तर
1983, Eli Lilly an American company prepared two DNA sequences corresponding to A and B, chains of human insulin and introduced them in plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulfide bonds to form human insulin.
APPEARS IN
संबंधित प्रश्न
Explain enzyme – replacement therapy to treat adenosine deaminase deficiency. Mention two disadvantages of this procedure.
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
Describe the steps that are followed during secondary treatment of sewage.
The first clinical gene therapy was done for the treatment of ________.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
The site of production of ADA the body is ______.
Who was the first patient who was given gene therapy? Why was the given treatment recurrent in nature?
How is a mature, functional insulin hormone different from its prohormone form?
A patient is suffering from ADA deficiency. Can he be cured? How?
Illustrate using any one example of transgenic bacteria.
